ZYVERSA THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.7M | $77.1M | $928.4K |
| FY2022 | $18.5M | $118.5M | $699.3K |
| FY2023 | $11.0M | $22.1M | $3.1M |
| FY2024 | $12.1M | $20.6M | $1.5M |
| FY2025 | $12.7M | $347.9K | $101.8K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.7M | $77.1M | $928.4K |
| FY2022 | $18.5M | $118.5M | $699.3K |
| FY2023 | $11.0M | $22.1M | $3.1M |
| FY2024 | $12.1M | $20.6M | $1.5M |
| FY2025 | $12.7M | $347.9K | $101.8K |